Correction to: Leukemia https://doi.org/10.1038/s41375-022-01556-7, published online 02 April 2022
Due to an error in the typesetting process of this article, the names of the authors have been set incorrectly. We have corrected this in the original article.
We apologise for the error.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Maschmeyer, G., Bullinger, L., Garcia-Vidal, C. et al. Correction: Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN). Leukemia 36, 1450 (2022). https://doi.org/10.1038/s41375-022-01570-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41375-022-01570-9
